Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments: Frankfurt, 21 - 22 May 1981
Saved in:
| Corporate Authors: | , |
|---|---|
| Format: | Conference Proceeding Book |
| Language: | English |
| Published: |
London [u.a.]
Acad. Press
1982
|
| Series: | Cancer treatment reviews
Supplement ; 9,A |
| Subjects: | |
| Item Description: | NT: Etoposide |
| Physical Description: | 142 S. graph. Darst. |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000908627 | ||
| 003 | DE-604 | ||
| 005 | 20071213 | ||
| 007 | t | ||
| 008 | 890313s1982 d||| |||| 10||| eng d | ||
| 035 | |a (OCoLC)8849577 | ||
| 035 | |a (DE-599)BVBBV000908627 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RC271.P6 | |
| 111 | 2 | |a Symposium on Etoposide (VP-16) Current Status and New Developments |d 1981 |c Frankfurt, Main |j Verfasser |0 (DE-588)5513593-6 |4 aut | |
| 245 | 1 | 0 | |a Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments |b Frankfurt, 21 - 22 May 1981 |c ed.: K. Hellmann ... |
| 246 | 1 | 3 | |a Etoposide |
| 264 | 1 | |a London [u.a.] |b Acad. Press |c 1982 | |
| 300 | |a 142 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Cancer treatment reviews : Supplement |v 9,A | |
| 500 | |a NT: Etoposide | ||
| 650 | 4 | |a Antineoplastic agents |v Congresses | |
| 650 | 4 | |a Neoplasms |x drug therapy |v Congresses | |
| 650 | 4 | |a Podophyllotoxin |v Congresses | |
| 650 | 4 | |a Podophyllotoxin |x pharmacology |v Congresses | |
| 650 | 4 | |a Podophyllotoxin |x therapeutic use |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Hellmann, Kurt |e Sonstige |4 oth | |
| 710 | 2 | |a Deutsche Krebsgesellschaft |b Arbeitsgemeinschaft für Internistische Onkologie |e Verfasser |0 (DE-588)2065660-9 |4 aut | |
| 830 | 0 | |a Cancer treatment reviews |v Supplement ; 9,A |w (DE-604)BV000900546 |9 9,A | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000560376 | ||
Record in the Search Index
| _version_ | 1804115346496421888 |
|---|---|
| any_adam_object | |
| author_corporate | Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, Main Deutsche Krebsgesellschaft Arbeitsgemeinschaft für Internistische Onkologie |
| author_corporate_role | aut aut |
| author_facet | Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, Main Deutsche Krebsgesellschaft Arbeitsgemeinschaft für Internistische Onkologie |
| author_sort | Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, Main |
| building | Verbundindex |
| bvnumber | BV000908627 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.P6 |
| callnumber-search | RC271.P6 |
| callnumber-sort | RC 3271 P6 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)8849577 (DE-599)BVBBV000908627 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01641nam a2200397 cb4500</leader><controlfield tag="001">BV000908627</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20071213 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890313s1982 d||| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)8849577</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000908627</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.P6</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Symposium on Etoposide (VP-16) Current Status and New Developments</subfield><subfield code="d">1981</subfield><subfield code="c">Frankfurt, Main</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)5513593-6</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments</subfield><subfield code="b">Frankfurt, 21 - 22 May 1981</subfield><subfield code="c">ed.: K. Hellmann ...</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Etoposide</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London [u.a.]</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">1982</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">142 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer treatment reviews : Supplement</subfield><subfield code="v">9,A</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">NT: Etoposide</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Podophyllotoxin</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Podophyllotoxin</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Podophyllotoxin</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hellmann, Kurt</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Deutsche Krebsgesellschaft</subfield><subfield code="b">Arbeitsgemeinschaft für Internistische Onkologie</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)2065660-9</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cancer treatment reviews</subfield><subfield code="v">Supplement ; 9,A</subfield><subfield code="w">(DE-604)BV000900546</subfield><subfield code="9">9,A</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000560376</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV000908627 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:21:09Z |
| institution | BVB |
| institution_GND | (DE-588)5513593-6 (DE-588)2065660-9 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000560376 |
| oclc_num | 8849577 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | 142 S. graph. Darst. |
| publishDate | 1982 |
| publishDateSearch | 1982 |
| publishDateSort | 1982 |
| publisher | Acad. Press |
| record_format | marc |
| series | Cancer treatment reviews |
| series2 | Cancer treatment reviews : Supplement |
| spelling | Symposium on Etoposide (VP-16) Current Status and New Developments 1981 Frankfurt, Main Verfasser (DE-588)5513593-6 aut Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, 21 - 22 May 1981 ed.: K. Hellmann ... Etoposide London [u.a.] Acad. Press 1982 142 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cancer treatment reviews : Supplement 9,A NT: Etoposide Antineoplastic agents Congresses Neoplasms drug therapy Congresses Podophyllotoxin Congresses Podophyllotoxin pharmacology Congresses Podophyllotoxin therapeutic use Congresses (DE-588)1071861417 Konferenzschrift gnd-content Hellmann, Kurt Sonstige oth Deutsche Krebsgesellschaft Arbeitsgemeinschaft für Internistische Onkologie Verfasser (DE-588)2065660-9 aut Cancer treatment reviews Supplement ; 9,A (DE-604)BV000900546 9,A |
| spellingShingle | Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, 21 - 22 May 1981 Cancer treatment reviews Antineoplastic agents Congresses Neoplasms drug therapy Congresses Podophyllotoxin Congresses Podophyllotoxin pharmacology Congresses Podophyllotoxin therapeutic use Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, 21 - 22 May 1981 |
| title_alt | Etoposide |
| title_auth | Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, 21 - 22 May 1981 |
| title_exact_search | Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, 21 - 22 May 1981 |
| title_full | Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, 21 - 22 May 1981 ed.: K. Hellmann ... |
| title_fullStr | Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, 21 - 22 May 1981 ed.: K. Hellmann ... |
| title_full_unstemmed | Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments Frankfurt, 21 - 22 May 1981 ed.: K. Hellmann ... |
| title_short | Proceedings of the German Cancer Society (Clinical Oncology Section) and Bristol-Myers GmbH Symposium on Etoposide (VP-16) Current Status and New Developments |
| title_sort | proceedings of the german cancer society clinical oncology section and bristol myers gmbh symposium on etoposide vp 16 current status and new developments frankfurt 21 22 may 1981 |
| title_sub | Frankfurt, 21 - 22 May 1981 |
| topic | Antineoplastic agents Congresses Neoplasms drug therapy Congresses Podophyllotoxin Congresses Podophyllotoxin pharmacology Congresses Podophyllotoxin therapeutic use Congresses |
| topic_facet | Antineoplastic agents Congresses Neoplasms drug therapy Congresses Podophyllotoxin Congresses Podophyllotoxin pharmacology Congresses Podophyllotoxin therapeutic use Congresses Konferenzschrift |
| volume_link | (DE-604)BV000900546 |
| work_keys_str_mv | AT symposiumonetoposidevp16currentstatusandnewdevelopmentsfrankfurtmain proceedingsofthegermancancersocietyclinicaloncologysectionandbristolmyersgmbhsymposiumonetoposidevp16currentstatusandnewdevelopmentsfrankfurt2122may1981 AT hellmannkurt proceedingsofthegermancancersocietyclinicaloncologysectionandbristolmyersgmbhsymposiumonetoposidevp16currentstatusandnewdevelopmentsfrankfurt2122may1981 AT deutschekrebsgesellschaftarbeitsgemeinschaftfurinternistischeonkologie proceedingsofthegermancancersocietyclinicaloncologysectionandbristolmyersgmbhsymposiumonetoposidevp16currentstatusandnewdevelopmentsfrankfurt2122may1981 AT symposiumonetoposidevp16currentstatusandnewdevelopmentsfrankfurtmain etoposide AT hellmannkurt etoposide AT deutschekrebsgesellschaftarbeitsgemeinschaftfurinternistischeonkologie etoposide |